Document Detail

The role of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
MedLine Citation:
PMID:  11602083     Owner:  NLM     Status:  MEDLINE    
Angiotensin-converting enzyme (ACE) inhibitors continue to find new uses. The Heart Outcomes Prevention Evaluation study has demonstrated their wide application as a preventive measure for patients at high risk of cardiovascular disease, but the available clinical trials in hypertensive subjects do not so far suggest any clear superiority over conventional treatment. The available trials may have been underpowered to detect non-blood pressure-related benefits on smooth muscle growth, endothelial function, left ventricular hypertrophy, and plaque rupture, when used in relatively low-risk subjects with uncomplicated hypertension. Clinical trials have also shown that two or more drugs are needed to lower blood pressure even to 140/90. Few patients have uncomplicated hypertension, so the choice of their drugs will be powerfully influenced by their other clinical problems. Nevertheless, there is a strong case for an attack on the renin-angiotensin system. Whether this will be by ACE inhibition, angiotensin-II receptor blockade, or both, is the subject of current clinical trials.
P Sleight
Related Documents :
1688983 - Effects of captopril on blood pressure and respiratory function compared to verapamil i...
3894513 - Depressor effects of captopril in doca-salt hypertensive rats: role of vasopressin.
3941473 - The effect of modified transurethral sphincterotomy on autonomic dysreflexia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current cardiology reports     Volume:  3     ISSN:  1523-3782     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2001 Nov 
Date Detail:
Created Date:  2001-10-16     Completed Date:  2001-12-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  511-8     Citation Subset:  IM    
Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, England.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Blood Pressure / drug effects
Clinical Trials as Topic
Hypertension / drug therapy*
Hypertrophy, Left Ventricular / drug therapy
Randomized Controlled Trials as Topic
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Implications of recent heart failure trials for patients with hypertension.
Next Document:  Impact of meta-analysis in clinical practice: the example of psychiatry